Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04DMZ
|
|||
| Drug Name |
AVXS-101
|
|||
| Indication | Spinal muscular atrophy [ICD-11: 8B61] | Phase 3 | [1] | |
| Company |
AveXis Bannockburn, IL
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04851873) Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) (SMART). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.